NZ504246A - Production of virion-free thrombin recovered from whole plasma from which fibrinogen, Factor VIII and fibronectin have been precipitated - Google Patents

Production of virion-free thrombin recovered from whole plasma from which fibrinogen, Factor VIII and fibronectin have been precipitated

Info

Publication number
NZ504246A
NZ504246A NZ504246A NZ50424698A NZ504246A NZ 504246 A NZ504246 A NZ 504246A NZ 504246 A NZ504246 A NZ 504246A NZ 50424698 A NZ50424698 A NZ 50424698A NZ 504246 A NZ504246 A NZ 504246A
Authority
NZ
New Zealand
Prior art keywords
viral
thrombin
fibronectin
recovery
product
Prior art date
Application number
NZ504246A
Other languages
English (en)
Inventor
Trung Bui-Khac
Original Assignee
Haemacure Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Haemacure Corp filed Critical Haemacure Corp
Publication of NZ504246A publication Critical patent/NZ504246A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/45—Transferases (2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0011—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
    • A61L2/0017—Filtration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/02—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using physical phenomena
    • A61L2/022—Filtration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/10—Polypeptides; Proteins
    • A61L24/106—Fibrin; Fibrinogen
    • A61L2103/05—
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/906—Drug delivery
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/908—Mechanical repair performed/surgical
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/92—Detection of biochemical

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Surgery (AREA)
  • Hematology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Materials For Medical Uses (AREA)
NZ504246A 1997-10-30 1998-10-29 Production of virion-free thrombin recovered from whole plasma from which fibrinogen, Factor VIII and fibronectin have been precipitated NZ504246A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/960,660 US5981254A (en) 1997-10-30 1997-10-30 Process for producing thrombin from plasma
PCT/CA1998/001008 WO1999023111A1 (en) 1997-10-30 1998-10-29 Process for the production of highly viral safe components for forming fibrin glue from a pool of human plasma

Publications (1)

Publication Number Publication Date
NZ504246A true NZ504246A (en) 2002-09-27

Family

ID=25503448

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ504246A NZ504246A (en) 1997-10-30 1998-10-29 Production of virion-free thrombin recovered from whole plasma from which fibrinogen, Factor VIII and fibronectin have been precipitated

Country Status (16)

Country Link
US (1) US5981254A (OSRAM)
EP (1) EP1027371B1 (OSRAM)
JP (1) JP4278861B2 (OSRAM)
AT (1) ATE305011T1 (OSRAM)
AU (1) AU759145B2 (OSRAM)
CA (1) CA2307380A1 (OSRAM)
DE (1) DE69831684T2 (OSRAM)
DK (1) DK1027371T3 (OSRAM)
ES (1) ES2249843T3 (OSRAM)
IL (1) IL135812A (OSRAM)
IN (1) IN185759B (OSRAM)
NO (1) NO323299B1 (OSRAM)
NZ (1) NZ504246A (OSRAM)
PL (1) PL194589B1 (OSRAM)
RU (1) RU2236237C2 (OSRAM)
WO (1) WO1999023111A1 (OSRAM)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT407484B (de) * 1997-11-12 2001-03-26 Bio Prod & Bio Eng Ag Arzneimittel zur förderung der wundheilung
JP5080713B2 (ja) * 1999-12-20 2012-11-21 田辺三菱製薬株式会社 多孔性膜処理によるウイルスの除去された血漿蛋白組成物の製造方法、ウイルスの除去された血漿蛋白組成物およびウイルス除去方法
AU779126B2 (en) * 1999-12-23 2005-01-06 Csl Limited Separation of fibrinogen from plasma proteases
WO2001048016A1 (en) * 1999-12-23 2001-07-05 Csl Limited Separation of fibrinogen from plasma proteases
JP2002114799A (ja) * 2000-08-01 2002-04-16 Nihon Pharmaceutical Co Ltd ウイルス除去方法
US7411006B2 (en) 2000-10-23 2008-08-12 Shanbrom Technologies, Llc Enhanced production of blood clotting factors and fibrin fabric
US7365173B2 (en) * 2002-02-04 2008-04-29 American National Red Cross Method for the production of pure virally inactivated butyrylcholinesterase
DE10211632A1 (de) * 2002-03-15 2003-10-09 Aventis Behring Gmbh Verfahren zur Abtrennung von Viren aus einer Proteinlösung durch Nanofiltration
US20070015230A1 (en) * 2002-04-15 2007-01-18 Hammond David J Identification and characterization of analytes from whole blood
US20060275753A1 (en) * 2002-04-15 2006-12-07 Hammond David J Recovery of analytes using combinatorial libraries
US20060275829A1 (en) * 2002-04-15 2006-12-07 Hammond David J Combinatorial library for proteomic investigations
CN100525829C (zh) * 2002-04-15 2009-08-12 美国国家红十字会 检测混合物中配体和靶标的方法
GB0216001D0 (en) 2002-07-10 2002-08-21 Nat Blood Authority Process and composition
DK1528930T3 (da) * 2002-07-23 2009-08-03 Bio & Bio Licensing Sa Thrombindannelsesdygtige og thrombinholdige farmaceutiske præparater af virksomt stof samt lægemidler
ES2214967B1 (es) * 2003-03-06 2005-06-16 Probitas Pharma, S.A Procedimiento para la eliminacion de virus en soluciones de fibrinogeno y fibrinogeno obtenido por dicho procedimiento.
ES2926359T3 (es) * 2003-12-01 2022-10-25 Novo Nordisk Healthcare Ag Filtración de virus de composiciones líquidas del Factor VII
WO2006009989A1 (en) * 2004-06-22 2006-01-26 Zymogenetics, Inc. Thrombin compositions
DE102004044429B4 (de) * 2004-09-14 2009-04-30 Biotest Ag Verfahren zur Herstellung einer Zusammensetzung enthaltend von Willebrand Faktor
ES2226587B1 (es) * 2004-10-22 2005-12-16 Probitas Pharma, S.A. Composicion de trombina estable.
US20060270015A1 (en) * 2005-05-26 2006-11-30 Dan Pawlak Thrombin purification
FR2887883B1 (fr) 2005-06-29 2007-08-31 Lab Francais Du Fractionnement Procede de separation des proteines fibrinogene, facteur xiii et colle biologique d'une fraction plasmatique solubilisee et de preparation de concentres lyophilises desdites proteines
US20120195953A1 (en) * 2007-09-19 2012-08-02 Kieu Hoang Fibrin sealant (FIBRINGLURAAS) consisting of a kit of lyophilized high concentrate fribinogen intentionally enriched and preserved with fibronolysis inhibitor A1AT
RU2369410C1 (ru) * 2008-05-06 2009-10-10 Александр Николаевич Данилин Способ очистки биологической жидкости организма (крови) от вирусной инфекции путем сорбции на магнитоуправляемых наночастицах и устройство для его осуществления
GB0814570D0 (en) * 2008-08-08 2008-09-17 Diagnostics For The Real World Isolation of nucleic acid
US9011846B2 (en) 2011-05-02 2015-04-21 Biomet Biologics, Llc Thrombin isolated from blood and blood fractions
AU2013322604B2 (en) * 2012-09-26 2018-01-18 Bone Therapeutics S.A. Formulations involving solvent/detergent-treated plasma (S/D plasma) and uses thereof
RU2583931C2 (ru) * 2014-06-11 2016-05-10 Федеральное государственное бюджетное учреждение Гематологический научный центр Министерства здравоохранения РФ Способ получения концентрата тромбина
US9932388B2 (en) 2014-11-13 2018-04-03 Hemarus Therapeutics Limited Chromatographic process for producing high purity fibrinogen and thrombin
JP6666757B2 (ja) * 2016-03-10 2020-03-18 日本メジフィジックス株式会社 ポリオキシエチレン系非イオン界面活性剤の定量方法及び放射性医薬品製剤の製造方法
PE20210457A1 (es) * 2018-02-19 2021-03-08 Bayer Healthcare Llc Membrana de filtro modificada y metodo
WO2020229521A1 (en) 2019-05-14 2020-11-19 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods for inhibiting or reducing bacterial biofilms on a surface
CN113754757B (zh) * 2021-07-01 2024-06-14 华兰生物工程股份有限公司 一种人纤维蛋白原的制备方法
WO2023020914A1 (en) 2021-08-18 2023-02-23 Biotest Ag Dry heat treatment of plasma-derived factor viii
KR20230121373A (ko) * 2022-02-11 2023-08-18 주식회사 녹십자 인자 xiii의 정제방법

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3843126C3 (de) * 1988-12-22 1994-10-06 Octapharma Ag Verfahren zur Herstellung eines hochreinen Thrombinkonzentrates
RU2030183C1 (ru) * 1989-07-13 1995-03-10 Наталья Юрьевна Шатковская Состав для соединения биопластических материалов в отохирургии
RU2049470C1 (ru) * 1990-04-20 1995-12-10 Новокузнецкий институт усовершенствования врачей Способ получения альфа-макроглобулина
FR2679251B1 (fr) * 1991-07-18 1993-11-12 Nord Assoc Essor Transfusion San Procede de preparation d'un concentre de thrombine humaine destine a un usage therapeutique.
US5290918A (en) * 1993-02-23 1994-03-01 Haemacure Biotech Inc. Process for the obtention of a biological adhesive made of concentrated coagulation factors by acidic precipitation
US5395923A (en) * 1993-02-23 1995-03-07 Haemacure-Biotech, Inc. Process for the obtention of a biological adhesive made of concentrated coagulation factors by "salting-out"
US5506127A (en) * 1994-09-21 1996-04-09 Proba; Zbigniew Therapeutic grade thrombin produced by chromatography
RU2062103C1 (ru) * 1994-09-29 1996-06-20 Московская медицинская академия им.И.М.Сеченова Способ получения концентрата фибриногена

Also Published As

Publication number Publication date
JP2001521941A (ja) 2001-11-13
CA2307380A1 (en) 1999-05-14
US5981254A (en) 1999-11-09
AU759145B2 (en) 2003-04-03
PL340300A1 (en) 2001-01-29
EP1027371B1 (en) 2005-09-21
ES2249843T3 (es) 2006-04-01
DE69831684D1 (de) 2006-02-02
NO323299B1 (no) 2007-03-05
PL194589B1 (pl) 2007-06-29
RU2236237C2 (ru) 2004-09-20
DE69831684T2 (de) 2006-06-22
AU9731698A (en) 1999-05-24
IL135812A (en) 2007-09-20
WO1999023111A1 (en) 1999-05-14
JP4278861B2 (ja) 2009-06-17
IN185759B (OSRAM) 2001-04-21
IL135812A0 (en) 2001-05-20
NO20002293D0 (no) 2000-04-28
NO20002293L (no) 2000-06-30
ATE305011T1 (de) 2005-10-15
DK1027371T3 (da) 2006-01-09
EP1027371A1 (en) 2000-08-16

Similar Documents

Publication Publication Date Title
NZ504246A (en) Production of virion-free thrombin recovered from whole plasma from which fibrinogen, Factor VIII and fibronectin have been precipitated
ATE553125T1 (de) Herstellung eines multimeren proteins durch zellfusionsverfahren
MY113939A (en) Method to produce cyclic esters.
ATE358717T1 (de) Herstellung enzymatisch aktiver, rekombinanter carboxypeptidase b
EP0125520A3 (en) A process and a plant for the recovery of one or more constituents from a gas mixture
KR930016433A (ko) α-글리코실-L-아스코르브산 고함유물의 제조방법 및 그 제조를 위한 분리 시스템
CA2301371A1 (en) Process for bleaching lignocellulose pulp
DE3432083A1 (de) Pasteurisierte, isoagglutininfreie faktor viii-praeparation und verfahren zu ihrer herstellung
AU6487286A (en) Antihemophilic factor by cold precipitation
US5395497A (en) Process for the manufacture of an aqueous solution of sodium hydroxide
DK0716067T3 (da) Fremgangsmåde til fremstilling af xylitol
KR850006538A (ko) 흡착-탈착 사이클에 의한 산소 제조공정
JPH05227983A (ja) 米糠蛋白誘導ペプチドの製造方法
CN116376882A (zh) 一种低温等离子体辅助低共熔溶剂提取木瓜蛋白酶的方法
EP0348883A3 (en) Process for purifying sucrose fatty acid esters having a high hydrophilic-lipophilic balance
IT1199809B (it) Procedimento per la separazione ed il recupero di composti del boro da una salamoia geotermica
DK1071635T3 (da) Fremgangsmåde til rensning af alkalimetalsilicatopløsninger
IT1287127B1 (it) Procedimento di fabbricazione di una soluzione acquosa di idrossido di sodio
KR20010079285A (ko) 누에고치를 이용한 기능성 실크아미노산·펩타이드 소재의제조방법중 효소분해법에의한 제조방법
SU1137698A1 (ru) Способ получения цис-диамминдихлородигидроксоплатины (iy)
NO960770L (no) Fremgangsmåte ved behandling av væsker
JPH0272874A (ja) イネモミガラパーオキシターゼの製造方法
Brown et al. Bayer Process Caustic Alkali Solution Purification
RU93006373A (ru) Способ получения щелочи цезия или рубидия и кислоты
BR8907832A (pt) Processo para a geracao eletroquimica de pentoxido de dinitrogenio e pentoxido de dinitrogenio obtido

Legal Events

Date Code Title Description
PSEA Patent sealed
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)